APA (7th ed.) Citation

CD, L., A, K., EY, C., G, P., A, G., B, F., . . . RC, S. (2024). CASPER: A Phase I trial combining calaspargase pegol-mnkl and cobimetinib in pancreatic cancer. Future oncology (London, England), 20(37), 2915. https://doi.org/10.1080/14796694.2024.2395235

Chicago Style (17th ed.) Citation

CD, Lopez, et al. "CASPER: A Phase I Trial Combining Calaspargase Pegol-mnkl and Cobimetinib in Pancreatic Cancer." Future Oncology (London, England) 20, no. 37 (2024): 2915. https://doi.org/10.1080/14796694.2024.2395235.

MLA (9th ed.) Citation

CD, Lopez, et al. "CASPER: A Phase I Trial Combining Calaspargase Pegol-mnkl and Cobimetinib in Pancreatic Cancer." Future Oncology (London, England), vol. 20, no. 37, 2024, p. 2915, https://doi.org/10.1080/14796694.2024.2395235.